# Contineum Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:5a7470a4-6236-4baa-b54c-8d45690b3c92 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/contineum-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 15 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-08T04:46:15.670059+00:00 |
| Last reviewed | 2026-10-08T04:46:15.670059+00:00 |

## Identity

- Legal name: Contineum Therapeutics, Inc.
- Display name: Contineum Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce |
| As of | 2026-10-08T16:38:06.189702+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.824 |
| Directors | 4 |
| Committees | 5 |
| Governance events | 8 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Olivia Ware: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:5
- Sarah Boyce: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:6
- Troy Ignelzi: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:7
- Troy Ignelzi: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (chair). claim_id=alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_record:9

## Committees

- Audit (audit). Chair: Troy Ignelzi. Members: Troy Ignelzi (chair, current); Troy Ignelzi (chair, unknown). committee_id=alpha:committee:contineum-therapeutics-inc:audit
- Compensation (compensation). Chair: NOT_PUBLISHED. Members: Olivia Ware (member, current); Olivia Ware (member, unknown). committee_id=alpha:committee:contineum-therapeutics-inc:compensation
- Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Olivia Ware (member, current). committee_id=alpha:committee:contineum-therapeutics-inc:compensation-nominating-and-governance
- Nominating and Governance (nominating_governance). Chair: Sarah Boyce. Members: Sarah Boyce (chair, current); Olivia Ware (member, current); Sarah Boyce (chair, unknown); Olivia Ware (member, unknown). committee_id=alpha:committee:contineum-therapeutics-inc:nominating-and-governance
- Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Sarah Boyce (member, current). committee_id=alpha:committee:contineum-therapeutics-inc:nominating-and-governance-chair

## Executive leadership

- Carmine N. Stengone: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:8

## Governance events

- CEO_CHANGED: Carmine N. Stengone executive of Contineum Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:ceo_changed:xhvbun
- DIRECTOR_APPOINTED: Olivia Ware seat on Contineum Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:director_appointed:15h9o42
- DIRECTOR_APPOINTED: Sarah Boyce seat on Contineum Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:director_appointed:1ryfcz1
- DIRECTOR_APPOINTED: Troy Ignelzi seat on Contineum Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:director_appointed:torwue
- COMMITTEE_CREATED: Compensation; Nominating and Governance committee of Contineum Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:committee_created:1byeyac
- COMMITTEE_MEMBER_ADDED: Olivia Ware member of Compensation; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:committee_member_added:78w9qp
- COMMITTEE_CREATED: Nominating and Governance · Chair committee of Contineum Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:committee_created:1x7ihae
- COMMITTEE_MEMBER_ADDED: Sarah Boyce member of Nominating and Governance · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-08T04:46:15.670059+00:00. event_id=alpha:event:committee_member_added:1eosrl6

## Scoped resources

- `alpha://company/contineum-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record
- `alpha://company/contineum-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=identity
- `alpha://company/contineum-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/contineum-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=board
- `alpha://company/contineum-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=committees
- `alpha://company/contineum-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=leadership
- `alpha://company/contineum-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=ownership
- `alpha://company/contineum-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=financials
- `alpha://company/contineum-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/contineum-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=compensation
- `alpha://company/contineum-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=governance
- `alpha://company/contineum-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/contineum-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=audit
- `alpha://company/contineum-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=legal
- `alpha://company/contineum-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=risk
- `alpha://company/contineum-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=cyber
- `alpha://company/contineum-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/contineum-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=agents
- `alpha://company/contineum-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/contineum-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=events
- `alpha://company/contineum-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=relationships
- `alpha://company/contineum-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=assessments
- `alpha://company/contineum-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:10: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:troy-ignelzi","name":"Troy Ignelzi"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:12: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:olivia-ware","name":"Olivia Ware"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:sarah-boyce","name":"Sarah Boyce"},"source_id":"board_seats"}`
- Claim alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:olivia-ware","name":"Olivia Ware"},"source_id":"board_seats"}`

## Leadership

- Olivia Ware: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:5. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c.
- Sarah Boyce: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:6. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c.
- Troy Ignelzi: Director. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c.
- Carmine N. Stengone: President, Chief Executive Officer and Director. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:leadership_role:8. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:df370dd3cb6f6d8d23f4c42b8f8f041a06f7150980b5566d846b0c787b314feb.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Troy Ignelzi; Members Troy Ignelzi (Chair). Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_record:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.
- Compensation: Chair not stated; Members Olivia Ware. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_record:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.
- Nominating and Governance: Chair Sarah Boyce; Members Sarah Boyce (Chair); Olivia Ware. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Contineum Therapeutics, Inc.. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:71f5eae5077d1f4316f200242978d4fcdbad58eb16a9b0198721ea146c63f12b.

## Entity Status

- Public listing published. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:71f5eae5077d1f4316f200242978d4fcdbad58eb16a9b0198721ea146c63f12b.

## Published Fact

- US. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:71f5eae5077d1f4316f200242978d4fcdbad58eb16a9b0198721ea146c63f12b.

## Committee Appointment

- Troy Ignelzi: chair, Audit. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.
- Olivia Ware: member, Compensation. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.
- Sarah Boyce: chair, Nominating and Governance. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.
- Olivia Ware: member, Nominating and Governance. Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799.

## Security Listing

- CTNM (NASDAQ). Claim: alpha:claim:company:5a7470a4-6236-4baa-b54c-8d45690b3c92:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:71f5eae5077d1f4316f200242978d4fcdbad58eb16a9b0198721ea146c63f12b.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:71f5eae5077d1f4316f200242978d4fcdbad58eb16a9b0198721ea146c63f12b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/contineum-therapeutics-inc).
- alpha:projection-evidence:document:8c9cc401961b5435d88f3d60a4da23d5438563f71ac230c38b09da2d8158d51c: [Contineum Therapeutics, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1855175/000143774925013528/cont20250319_def14a.htm).
- alpha:projection-evidence:document:df370dd3cb6f6d8d23f4c42b8f8f041a06f7150980b5566d846b0c787b314feb: [CTNM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1855175/000162828026028881/ctnm-20260430.htm).
- alpha:projection-evidence:ff27e184b1828f031b806654792c29c87af3f34301bbbaafb0f2a5d750350799: [Audit](https://www.sec.gov/Archives/edgar/data/1855175/000143774925013528/cont20250319_def14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/contineum-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/contineum-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/contineum-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/contineum-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.